Clinical Trials Browser

Phase 1/2 × Triple Negative Breast Neoplasms × toripalimab × Clear all

Triple Negative Breast Neoplasms

NCT05955105 2024-05-21

A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

BreastDermatologicGynecologicHead & NeckSarcomaThoracic

Nasopharyngeal Carcinoma, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05103917 2021-11-02

A Study to Assess the Safety, Tolerability and Antitumor Activity of X4P-001 in Combination With TNBC

Phase 1/2 Unknown

24 enrolled

Breast

Triple Negative Breast Neoplasms

Clinical Trials

A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer

A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

A Study to Assess the Safety, Tolerability and Antitumor Activity of X4P-001 in Combination With TNBC